(Q36429450)

14 August 2017

1 reference

title

Cancer scene investigation: how a cold virus became a tumor killer (English)

1 reference

14 August 2017

4

1 reference

14 August 2017

Dawn E Post

1

1 reference

14 August 2017

Hyunsuk Shim

series ordinal

2

1 reference

14 August 2017

Esra Toussaint-Smith

series ordinal

3

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

14 August 2017

1 reference

14 August 2017

1

1 reference

14 August 2017

2

1 reference

14 August 2017

247-258

1 reference

Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial

14 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.247

Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.247

E1B-deleted adenovirus (dl1520) gene therapy for patients with primary and secondary liver tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.247

Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.247

Pilot trial of intravenous infusion of a replication-selective adenovirus (ONYX-015) in combination with chemotherapy or IL-2 treatment in refractory cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.247

A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.247

An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.247

A prospective phase II trial of ONYX-015 adenovirus and chemotherapy in recurrent squamous cell carcinoma of the head and neck (the Baylor experience).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.247

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.247

Phase II Trial of Intravenous CI-1042 in Patients With Metastatic Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.247

The dl1520 virus is found preferentially in tumor tissue after direct intratumoral injection in oral carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14796694.1.2.247

21 January 2018

Identifiers

DOI

10.1517/14796694.1.2.247

1 reference

14 August 2017

1 reference